---
figid: PMC3913061__nihms549305f1
figtitle: 'BRAFV600E and microenvironment in thyroid cancer: a functional link to
  drive cancer progression'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Mus musculus
- Drosophila melanogaster
pmcid: PMC3913061
filename: nihms549305f1.jpg
figlink: /pmc/articles/PMC3913061/figure/F1/
number: F1
caption: The BRAFV600E oncoprotein elicits dramatically an increased kinase activity
  and activates phospho-ERK1/2. This oncoprotein is constitutively active and does
  not require RAS signaling. The BRAFV600E -activated phospho-ERK1/2 pathway is able
  to transform normal thyroid cells (NT) to thyroid cancer cells (TC). It up-regulates
  some extracellular matrix (ECM) non-cellular components (i.e. Thrombospondin-1 (TSP-1),
  Fibronectin) and cellular trans-membrane receptors (e.g. integrins), which together
  may increase the levels of phospho-ERK1/2 through a positive feedback driven by
  TSP-1. These pathological processes trigger ECM remodeling and determines tumor
  cell invasion into the lymphatic (LV) and/or blood vessels (BV) through basement
  membrane causing thyroid cancer progression.
papertitle: 'BRAFV600E and microenvironment in thyroid cancer: a functional link to
  drive cancer progression.'
reftext: Carmelo Nucera, et al. Cancer Res. ;71(7):2417-2422.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8847178
figid_alias: PMC3913061__F1
figtype: Figure
redirect_from: /figures/PMC3913061__F1
ndex: b7bd2749-df17-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3913061__nihms549305f1.html
  '@type': Dataset
  description: The BRAFV600E oncoprotein elicits dramatically an increased kinase
    activity and activates phospho-ERK1/2. This oncoprotein is constitutively active
    and does not require RAS signaling. The BRAFV600E -activated phospho-ERK1/2 pathway
    is able to transform normal thyroid cells (NT) to thyroid cancer cells (TC). It
    up-regulates some extracellular matrix (ECM) non-cellular components (i.e. Thrombospondin-1
    (TSP-1), Fibronectin) and cellular trans-membrane receptors (e.g. integrins),
    which together may increase the levels of phospho-ERK1/2 through a positive feedback
    driven by TSP-1. These pathological processes trigger ECM remodeling and determines
    tumor cell invasion into the lymphatic (LV) and/or blood vessels (BV) through
    basement membrane causing thyroid cancer progression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Hras
  - Kras
  - Rem1
  - Map2k1
  - Mapk3
  - Gzma
  - Thbs1
  - nt
  - Ras64B
  - Ras85D
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - scb
  - Dsor1
  - hep
  - rl
  - MKP-4
  - p38b
  - tc
  - bv
  - Itgbn
  - Tyrosine
---
